3,4-dihydroxyphenylacetic acid has been researched along with a-Synucleinopathies in 1 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The three synucleinopathies therefore have in common in vivo evidence of central noradrenergic deficiency but differ in the extents of central dopaminergic deficiency-prominent in PD and MSA, less apparent in PAF." | 1.62 | Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies. ( Goldstein, DS; Holmes, C; Lamotte, G; Lenka, A; Sharabi, Y; Sullivan, P, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, DS | 1 |
| Sullivan, P | 1 |
| Holmes, C | 1 |
| Lamotte, G | 1 |
| Lenka, A | 1 |
| Sharabi, Y | 1 |
1 other study available for 3,4-dihydroxyphenylacetic acid and a-Synucleinopathies
| Article | Year |
|---|---|
Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Cohort Studies; Dopamine; Dopaminergic Neurons; Female; Homova | 2021 |